CAH241227C117000
- 1.59
- 0.000.00%
Cardinal Health Newsroom
Express News | Cardinal Health: Routine Production to Increase Availability of Ac-225
Express News | Cardinal Health: Start of Weekly Production of Actinium-225 Through Center for Theranostics Advancement in Indianapolis, in
Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5056
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Cardinal Health Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $136
Zacks.com Featured Highlights The Gap, Cardinal Health, Applied Industrial, Jones Lang LaSalle and United Airlines
Is Cardinal Health (CAH) a Great Value Stock Right Now?
President-Elect Donald J. Trump Says 'We're Going To Knock Out The Middlemen' Who Are Keeping Drug Prices High
5 Stocks With Upgraded Broker Ratings to Buy for Solid Returns in 2025
This PayPal Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Cardinal Health Raised to Equal-Weight From Underweight by Wells Fargo
Cardinal Health Analyst Ratings
Wells Fargo Upgrades Cardinal Health(CAH.US) to Hold Rating, Raises Target Price to $127
Zacks Industry Outlook Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems
ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife
India Drug Delivery Devices Market 2024, With Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma
T2 Biosystems Announces Plans to License Its Proprietary Technology to Expand Its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens